Infliximab therapy in a patient with Crohn's disease and chronic hepatitis B virus infection.
María
M
del Valle García-Sánchez
Federico
F
Gómez-Camacho
Antonio
A
Poyato-González
Eva María
EM
Iglesias-Flores
Juan Francisco
JF
de Dios-Vega
Rocio
R
Sancho-Zapatero
D000328:Adult; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D003424:Crohn Disease / Q000150:complications* / Q000188:drug therapy*; D018450:Disease Progression; D005765:Gastrointestinal Agents / Q000009:adverse effects*; D019694:Hepatitis B, Chronic / Q000473:pathology*; D006801:Humans; D000069285:Infliximab; D008297:Male; D012008:Recurrence; D014409:Tumor Necrosis Factor-alpha
D000911:Antibodies, Monoclonal; D005765:Gastrointestinal Agents; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab